Learn

This activity aims to:

• Outline the seriousness of AF-associated stroke and recurrent stroke, with a particular emphasis on understanding which patients cannot safely take oral anticoagulation therapy and which patients continue to stroke despite treatment
• Raise awareness amongst GPs of the option for left atrial appendage closure in such patients as a stroke risk mitigation therapy in appropriately selected patients
• Assist GPs in identifying which patients would benefit from a discussion with a multidisciplinary team regarding LAA closure

Sponsored by: Abbott Medical

Learning Outcomes

1. Summarise the pathophysiology, epidemiology and impact of atrial fibrillation-associated stroke and recurrent stroke in Australia
2. Outline current Australian guidelines pertaining to the management of non-valvular atrial fibrillation
3. Describe the contraindications to oral anticoagulation therapy
4. Describe the role of the left atrial appendage in AF-associated stroke, and current available options for its closure
5. Illustrate which AF and/or stroke patients benefit from a discussion with a multidisciplinary team regarding the utility of LAA closure as a stroke mitigation therapy.

Details

Disclaimer: Please note, once you click 'Register now' you will be leaving the AMA’s CPD Home website and entering a third-party education provider’s website. If you choose to register for this learning, you will need to provide some of your personal information directly to the third-party education provider. If you have any queries about how third-party education providers use, disclose or store your personal information you should consult their privacy policy.

Upon completion, your CPD activity record may take up to 48 hours to be reflected on your CPD Home Dashboard.